Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Catharina Ziekenhuis Eindhoven | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.
The investigators aim to optimize implementation of opportunistic salpingectomy throughout the Netherlands. The investigators will evaluate the implementation by enrolling patients in a database to evaluate healthcare experiences and to register EOC diagnosis and vital status through yearly PALGA (the nationwide network and registry of histopathology and cytopathology in the Netherlands) and municipal administration searches. In addition, the investigators will perform medical record check to assess which percentage of eligible women have been offered OS.
The investigators expect that a decision aid will be a necessary tool for the decision whether women opt for an OS or not, based on their personal values. After development of the tool(s), the investigators will evaluate the implementation process.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Choice for Opportunistic Salpingectomy | Women who will undergo a gynaecological surgery in which currently both ovaries and fallopian tubes would be preserved, can opt for an opportunistic salpingectomy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Opportunistic Salpingectomy | Procedure | An opportunistic salpingectomy refers to removal of the fallopian tubes without the ovaries during (laparoscopic) interventions for benign (gynaecological) disease to reduce the number of ovarian cancer cases. |
| Measure | Description | Time Frame |
|---|---|---|
| Offered Opportunistic Salpingectomy (OS) | Number of eligible women who have actually been offered an opportunistic salpingectomy in the Netherlands. | 2019 - 2023 |
| Implementation effect of Opportunistic Salpingectomy (OS) | The effect of our implementation efforts on the number of eligible women who have actually been offered an opportunistic salpingectomy in the Netherlands. | 2019-2023 |
| Measure | Description | Time Frame |
|---|---|---|
| Influencing factors implementation Opportunistic Salpingectomy (OS) | Determine factors that impede and facilitate nationwide implementation of Opportunistic Salpingectomy. | 2019-2020 |
| Implementation tools |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Women who will undergo a gynaecological surgery in which currently both ovaries and fallopian tubes would be preserved, can opt for an opportunistic salpingectomy.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joanne A de Hullu, MD, PhD | University Medical Center Nijmegen | Principal Investigator |
| Jurgen MJ Piek, MD, PhD | Catharina Ziekenhuis Eindhoven | Principal Investigator |
| Rosella PM Hermens, PhD | Scietific Institute for Quality of Healthcare, UMC Nijmegen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jeroen Bosch Hospital | 's-Hertogenbosch | 5223 GZ | Netherlands | |||
| OLVG |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26773418 | Background | Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis. Eur J Cancer. 2016 Mar;55:38-46. doi: 10.1016/j.ejca.2015.12.003. Epub 2016 Jan 8. | |
| 25568991 | Background | Kwon JS, McAlpine JN, Hanley GE, Finlayson SJ, Cohen T, Miller DM, Gilks CB, Huntsman DG. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy. Obstet Gynecol. 2015 Feb;125(2):338-345. doi: 10.1097/AOG.0000000000000630. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Implementation tools, developed based on the barriers and facilitators of the influencing factors.
| 2019-2020 |
| Amsterdam |
| 1091 AC |
| Netherlands |
| Academic Medical Centrum | Amsterdam | 1105AZ | Netherlands |
| Rijnstate Hospital | Arnhem | 6800 TA | Netherlands |
| Amphia hospital | Breda | 4818 CK | Netherlands |
| Reinier de Graaf | Delft | 2625 AD | Netherlands |
| Slingeland Hospital | Doetinchem | 7009 BL | Netherlands |
| Albert Schweitzer hospital | Dordrecht | 3300 AK | Netherlands |
| Catharina Hospital | Eindhoven | 5623 EJ | Netherlands |
| Medical Spectrum Twente | Enschede | 7500 KA | Netherlands |
| Martini hospital | Groningen | 9728 NT | Netherlands |
| Spaarne Gasthuis | Haarlem | 2000 AK | Netherlands |
| Ziekenhuisgroep Twente | Hengelo | 7555 DL | Netherlands |
| Medical Center Leewarden | Leeuwarden | 8934 AD | Netherlands |
| Leids University Medical Center | Leiden | 2300 RC | Netherlands |
| Maastricht University Medical Center | Maastricht | 6229 HX | Netherlands |
| St Antonius | Nieuwegein | 3434 CM | Netherlands |
| Radboud UMC | Nijmegen | 6525 GA | Netherlands |
| Canisius Wilhelmina Hospital | Nijmegen | 6532 SZ | Netherlands |
| Erasmus Medical Center | Rotterdam | 3000 CA | Netherlands |
| Haaglanden Medical Center Westeinde | The Hague | 2512 VA | Netherlands |
| Elisabeth-Tweesteden Hospital | Tilburg | 5042 AD | Netherlands |
| Diakonessenhuis | Utrecht | 3508 TG | Netherlands |
| Maxima Medical Center | Veldhoven | 5500 MB | Netherlands |
| VieCuri Medical Center | Venlo | 5801 CE | Netherlands |
| Sint Jans Gasthuis | Weert | 6001 BE | Netherlands |
| Isala | Zwolle | 8025 AB | Netherlands |
| 31456223 | Background | van Lieshout LAM, Steenbeek MP, De Hullu JA, Vos MC, Houterman S, Wilkinson J, Piek JM. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone. Cochrane Database Syst Rev. 2019 Aug 28;8(8):CD012858. doi: 10.1002/14651858.CD012858.pub2. |
| 30479086 | Background | Steenbeek MP, van Lieshout LAM, Aarts JWM, Piek JMJ, Coppus SFPJ, Massuger LFAG, Hermens RPMG, de Hullu JA. Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey. J Gynecol Oncol. 2019 Jan;30(1):e2. doi: 10.3802/jgo.2019.30.e2. Epub 2018 Apr 30. |
| 25560145 | Background | Committee opinion no. 620: Salpingectomy for ovarian cancer prevention. Obstet Gynecol. 2015 Jan;125(1):279-281. doi: 10.1097/01.AOG.0000459871.88564.09. |
| 28527613 | Background | Salvador S, Scott S, Francis JA, Agrawal A, Giede C. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population. J Obstet Gynaecol Can. 2017 Jun;39(6):480-493. doi: 10.1016/j.jogc.2016.12.005. |
| ID | Term |
|---|---|
| D040242 | Risk Reduction Behavior |
| D010051 | Ovarian Neoplasms |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
| D000291 | Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |
Not provided
Not provided